To which of the following therapeutic drug classes does pravastatin belong?

A. Prevention of exercise-induced bronchospasm is a labeled indication for albuterol sulfate. It is administered prophylactically to stabilize mast cells and prevent airway constriction. This ensures patent airways during physical exertion in patients with hyperreactive airway disease.

B. Allergic rhinitis involves inflammatory responses in the nasal mucosa rather than the lower respiratory tract. Albuterol is a sympathomimetic bronchodilator and lacks the antihistaminic or anti-inflammatory properties required for this condition. It provides no therapeutic benefit for nasal congestion.

C. Relief of bronchospasm in patients with reversible obstructive airway disease is the primary indication. Albuterol acts as a selective beta-2 adrenergic agonist to increase intracellular cyclic adenosine monophosphate. This results in the relaxation of bronchial smooth muscle and rapid bronchodilation.

D. Rhinorrhea associated with the common cold is caused by viral-induced nasal inflammation and increased glandular secretion. Albuterol does not possess the anticholinergic or vasoconstrictive effects needed to reduce nasal discharge. Its pharmacological activity is limited to the beta receptors of the bronchi.

A. Valtrex is the brand name for valacyclovir hydrochloride, an L-valyl ester prodrug of acyclovir. It undergoes rapid and nearly complete conversion to acyclovir by first-pass intestinal and hepatic metabolism. This process significantly increases the oral bioavailability of the antiviral compound.

B. Zovirax is the proprietary name for acyclovir, the active metabolite of valacyclovir hydrochloride. While both medications treat herpesvirus infections, they are distinct pharmaceutical products with different dosing frequencies. Zovirax is not the brand name for the prodrug valacyclovir.

C. Amerge is the brand name for naratriptan, a selective serotonin receptor agonist used for migraine treatment. It functions by stimulating 5-HT 1B and 1D receptors to cause cranial vasoconstriction. It lacks any antiviral properties and is not related to valacyclovir.

D. Relpax is the brand name for eletriptan, another member of the triptan class used for acute migraine. It modulates neurogenic inflammation and vasoconstriction via serotonin receptor agonism. It is not an antiviral agent and does not contain valacyclovir hydrochloride.